Skip to main content
TipRanks
Go Ultimate75% OFF

Lytix Biopharma AS (6BG) Ratios

3 Followers

Lytix Biopharma AS Ratios

DE:6BG's free cash flow for Q3 2026 was kr-23.87M. For the 2026 fiscal year, DE:6BG's free cash flow was increased by kr0.00 and operating cash flow was kr-23.87M. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 25Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio4.283.915.068.5515.22
Quick Ratio4.283.915.068.5515.22
Cash Ratio0.573.562.065.2514.79
Solvency Ratio-2.98-2.42-6.92-3.02-3.57
Operating Cash Flow Ratio-3.10-1.91-7.67-2.96-3.34
Short-Term Operating Cash Flow Coverage-58.89-92.350.000.000.00
Net Current Asset Valuekr 59.66Mkr 105.26Mkr 50.77Mkr 133.66Mkr 189.62M
Leverage Ratios
Debt-to-Assets Ratio0.040.020.010.010.00
Debt-to-Equity Ratio0.060.020.010.010.00
Debt-to-Capital Ratio0.050.020.010.010.00
Long-Term Debt-to-Capital Ratio0.020.000.000.000.00
Financial Leverage Ratio1.321.361.241.141.07
Debt Service Coverage Ratio-52.83-99.60-1551.38-376.11-720.61
Interest Coverage Ratio-317.83-551.13-1728.30-449.77-727.05
Debt to Market Cap0.000.000.000.000.00
Interest Debt Per Share0.050.050.010.040.00
Net Debt to EBITDA0.111.370.291.674.15
Profitability Margins
Gross Profit Margin0.00%-210.75%100.00%100.00%100.00%
EBIT Margin0.00%-845.59%-2200.98%-506.96%-248.68%
EBITDA Margin0.00%-837.37%-2176.82%-497.80%-246.34%
Operating Profit Margin0.00%-861.37%-2425.08%-595.29%-248.54%
Pretax Profit Margin0.00%-846.72%-2202.38%-508.29%-249.02%
Net Profit Margin0.00%-846.72%-2202.38%-508.29%-249.02%
Continuous Operations Profit Margin0.00%-846.72%-2202.38%-508.29%-249.02%
Net Income Per EBT100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT87.37%98.30%90.82%85.39%100.20%
Return on Assets (ROA)-73.58%-64.33%-137.61%-36.58%-23.69%
Return on Equity (ROE)-97.14%-87.37%-171.28%-41.52%-25.35%
Return on Capital Employed (ROCE)-109.02%-87.36%-188.44%-48.46%-25.31%
Return on Invested Capital (ROIC)-107.35%-86.16%-186.80%-48.15%-25.31%
Return on Tangible Assets-73.58%-64.33%-137.61%-36.58%-23.69%
Earnings Yield-8.86%-29.61%-43.87%-18.21%-9.03%
Efficiency Ratios
Receivables Turnover0.000.890.342.014.00
Payables Turnover0.166.900.000.000.00
Inventory Turnover0.000.000.000.000.00
Fixed Asset Turnover0.004.237.288.020.00
Asset Turnover0.000.080.060.070.10
Working Capital Turnover Ratio0.000.140.040.070.18
Cash Conversion Cycle-2318.33358.911076.25181.9991.20
Days of Sales Outstanding0.00411.821076.25181.9991.20
Days of Inventory Outstanding0.000.000.000.000.00
Days of Payables Outstanding2318.3352.910.000.000.00
Operating Cycle0.00411.821076.25181.9991.20
Cash Flow Ratios
Operating Cash Flow Per Share-0.84-1.30-2.40-1.33-1.15
Free Cash Flow Per Share-0.87-1.30-2.40-1.33-1.15
Dividend Paid and CapEx Coverage Ratio-1.000.00-1958.55-341.730.00
Capital Expenditure Coverage Ratio-1.000.00-1958.55-341.730.00
Operating Cash Flow Coverage Ratio-16.82-26.66-195.06-39.160.00
Operating Cash Flow to Sales Ratio0.00-6.32-24.05-4.77-2.31
Free Cash Flow Yield-8.84%-22.11%-47.93%-17.15%-8.37%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-11.23-3.38-2.28-5.49-11.08
Price-to-Sales (P/S) Ratio0.0028.5950.2027.9127.59
Price-to-Book (P/B) Ratio10.972.953.902.282.81
Price-to-Free Cash Flow (P/FCF) Ratio-11.31-4.52-2.09-5.83-11.94
Price-to-Operating Cash Flow Ratio-11.77-4.52-2.09-5.85-11.94
Price-to-Earnings Growth (PEG) Ratio0.230.16-0.041.99-0.34
Enterprise Value Multiple-10.63-2.04-2.01-3.93-7.05
Enterprise Value669.93M190.16M175.04M215.99M335.38M
EV to EBITDA-10.63-2.04-2.01-3.93-7.05
EV to Sales0.0017.0843.8619.5817.37
EV to Free Cash Flow-11.19-2.70-1.82-4.09-7.52
EV to Operating Cash Flow-11.64-2.70-1.82-4.10-7.52
Tangible Book Value Per Share0.901.991.283.404.89
Shareholders’ Equity Per Share0.901.991.283.404.89
Tax and Other Ratios
Effective Tax Rate0.000.000.000.000.00
Revenue Per Share0.000.210.100.280.50
Net Income Per Share-0.88-1.74-2.19-1.41-1.24
Tax Burden1.001.001.001.001.00
Interest Burden0.941.001.001.001.00
Research & Development to Revenue0.006.5215.834.131.23
SG&A to Revenue0.000.000.000.000.00
Stock-Based Compensation to Revenue0.000.081.050.120.21
Income Quality0.960.751.090.940.93

Currency in NOK